InvestSMART

Ragnar Metals Limited (ASX: DRK) - Announcements

- Current share price for DRK : $0.012

ASX company news and announcements for Ragnar Metals Limited (DRK) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Ragnar Metals Limited (DRK) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Ragnar Metals Limited (DRK), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Ragnar Metals Limited (DRK)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
- Initial Director's Interest Notice 15 Feb 2017 5:50PM $0.002 $0.012 risen by 500%
- Board Appointment and Company Update 10 Feb 2017 6:05PM $0.002 $0.012 risen by 500%
- Quarterly Activities Report and Quarterly Cashflow Report 31 Jan 2017 8:05PM $0.002 $0.012 risen by 500%
- Appendix 3B 28 Dec 2016 9:42AM $0.002 $0.012 risen by 500%
- Completion of Tranche 1 Funding Facility 28 Dec 2016 9:41AM $0.002 $0.012 risen by 500%
- Change of Address 28 Nov 2016 1:11PM $0.002 $0.012 risen by 500%
- Appendix 4G 18 Nov 2016 5:34PM $0.002 $0.012 risen by 500%
- Annual Report to shareholders 18 Nov 2016 5:33PM $0.002 $0.012 risen by 500%
- Trinity Corporate - Statutory Demand 18 Nov 2016 4:57PM $0.002 $0.012 risen by 500%
- Funding and Management Update 18 Nov 2016 3:46PM $0.002 $0.012 risen by 500%
- Quarterly Activities Report and Quarterly Cashflow Report 31 Oct 2016 7:32PM $0.002 $0.012 risen by 500%
- Genome Transaction Update 12 Oct 2016 5:36PM $0.002 $0.012 risen by 500%
- Suspension from official quotation 23 Sep 2016 10:08AM $0.002 $0.012 risen by 500%
- Trading Halt 21 Sep 2016 9:45AM $0.002 $0.012 risen by 500%
- Genome Transaction Update 16 Sep 2016 10:59AM $0.002 $0.012 risen by 500%
- Quarterly Activities Report and Quarterly Cashflow Report 29 Jul 2016 2:41PM $0.002 $0.012 risen by 500%
- Market Update - Genome CEO Australian Visit 30 Jun 2016 9:54AM $0.002 $0.012 risen by 500%
- Completion of Genome Due Diligence and Market Update 24 May 2016 9:53AM $0.002 $0.012 risen by 500%
- Quarterly Activities Report and Quarterly Cashflow Report 29 Apr 2016 5:30PM $0.002 $0.012 risen by 500%
- Results of General Meeting 12 Apr 2016 4:51PM $0.002 $0.012 risen by 500%
- Appendix 3y x 3 11 Apr 2016 5:30PM $0.003 $0.012 risen by 300%
- Appendix 3Y 11 Apr 2016 4:58PM $0.003 $0.012 risen by 300%
- Allotment of Shares 8 Apr 2016 5:17PM $0.003 $0.012 risen by 300%
- Non-Renounceable Rights Offer Closure & Notice of Shortfall 6 Apr 2016 6:41PM $0.003 $0.012 risen by 300%
- Correction to Information in Notice of Meeting 6 Apr 2016 6:36PM $0.003 $0.012 risen by 300%

76 - 100 of 411 results

Page 4 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.